Amneal Pharmaceuticals (STU:2DT) Ending Cash Position : €47 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Amneal Pharmaceuticals Ending Cash Position?

Amneal Pharmaceuticals's Ending Cash Position for the quarter that ended in Mar. 2024 was €47 Mil.

Amneal Pharmaceuticals's quarterly Ending Cash Position increased from Sep. 2023 (€90 Mil) to Dec. 2023 (€91 Mil) but then declined from Dec. 2023 (€91 Mil) to Mar. 2024 (€47 Mil).

Amneal Pharmaceuticals's annual Ending Cash Position declined from Dec. 2021 (€227 Mil) to Dec. 2022 (€33 Mil) but then increased from Dec. 2022 (€33 Mil) to Dec. 2023 (€91 Mil).

Amneal Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for Amneal Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amneal Pharmaceuticals Ending Cash Position Chart

Amneal Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

137.54

285.33

227.21

33.25

90.88

Amneal Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															141.10	105.76	89.58	90.88	47.49

Amneal Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Amneal Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	32.302	+	58.579
	=	91

Amneal Pharmaceuticals's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	91.179	+	-43.691
	=	47

Amneal Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Amneal Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Amneal Pharmaceuticals (STU:2DT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amneal Pharmaceuticals Inc (STU:2DT) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

AMRX:USA 2DT:Germany

Address

400 Crossing Boulevard, 3rd Floor, Bridgewater, NJ, USA, 08807

Website

https://www.amneal.com

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies.

Amneal Pharmaceuticals (STU:2DT) Headlines

No Headlines